Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany The Tender Involves The Conclusion Of Non-exclusive Discount Agreements For The Active Ingredient Tocilizumab Under An Open-house Model, As Per § 130a Abs. 8 Sgb V. Tocilizumab 2026-04-06
Germany The Tender Involves The Conclusion Of Non-exclusive Discount Agreements For Pharmaceuticals Under An Open-house Model For The Active Ingredient Flecainide. Flecainide 2026-04-06
Bulgaria Delivery Of Orthopedic Implants And Osteosynthesis Necessary For The Activity Of The Orthopedics And Traumatology Clinic At The University Hospital Prof. Dr. Stoyan Kirkovich Ad. 2026-04-07
Netherlands Market Consultation Umc Utrect Regarding Ct Scanners 2026-04-07
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-07
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2026-04-07
Denmark Market Dialogue Prior To The Tender For 24-hour Blood Pressure Monitors And Holter Devices 2026-04-07
Denmark Eu Tender For A Contract Regarding Efforts For Mental Health And Well-being For Employees In Aalborg Municipality 2026-04-07
France Supply Of Implantable And Consumable Medical Devices For Gynecology, Urology, Ophthalmology, Ent, Visceral And Digestive 2026-04-08
Germany Conclusion Not Excluding Drug Discount Agreement. According To § 130a Paragraph. 8 Sgb V Through An Openhouse Model For The Active Ingredient Golimumab (atccode According To Who 2026-04-08
Whats app